Upadacitinib Looks Effective for Psoriatic Arthritis Upadacitinib Looks Effective for Psoriatic Arthritis

Findings from a pair of phase 3 trials support use of the JAK inhibitor for psoriatic arthritis; it has already been approved for rheumatoid arthritis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news